About US
Contact us
-
Takeda preps for first Actos trial now opening in L.A.The first trial of a lawsuit linking the diabetes drug Actos with bladder cancer is about to begin. As Bloomberg reports, jury selection starts today in Los Angeles, as Takeda Pharmaceuticals gears2013/2/19
-
UPDATED: Novartis nixes $78M non-compete with VasellaThe news of Daniel Vasella's $78 million payoff from Novartis couldn't have surfaced at a worse time. Once again, the Swiss drugmaker ($NVS) became a lightning rod for executive-pay watchdogs. And t2013/2/18
-
SFDA issues Technical Requirements for the Study of New Natural MedicinesTo improve the legal system for registration, standardize the registration of traditional Chinese medicines and natural medicines and encourage innovation, the State Food and Drug Administration (SFDA2013/2/17
-
SFDA Commissioner Yin Li meets the Ambassador of Switzerland to ChinaOn the afternoon of February 4, 2013, Yin Li, Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Mr. Jacques de Watteville, the Ambassador of Switzerland to China, an2013/2/17
-
Merck loses 'bellwether' Fosamax caseYou win some and you lose some and this time, Merck ($MRK) lost to the tune of $285,000 when a jury said it was not up front about the risks of osteoporosis drugFosamax. And the sting of this loss was2013/2/7
-
GSK to hack jobs in Europe where austerity has taken tollEuropean austerity is taking on a very personal meaning at GlaxoSmithKline ($GSK).CEO Sir Andrew Wittysays more cost-cutting is coming, and the brunt of it will fall on workers and operations in Europ2013/2/7
-
Lallemand inaugurates its newest division - “Lallemand Health Solutions”Montreal, Canada... Lallemand Inc is pleased to announce the birth of its new division ‘’Lallemand Health Solutions’’. This new entity consolidates the internationally recognized probiotic manufacture2013/2/6
-
While BMS shops emerging markets brands, GSK wraps $900M buy in IndiaTwo consumer health deals, two Big Pharma approaches toward emerging markets. While Bristol-Myers Squibb ($BMY) is looking around for buyers for a portfolio of consumer brands in Latin America, GlaxoS2013/2/6
-
SFDA issues notice on implementation of electronic supervision of imported drugsTo implement the 2011-2015 Work Plan for Electronic Supervision of Drugs and other related work requirements, the State Food and Drug Administration (SFDA) recently issued a notice on implementation o2013/2/5
-
FDA approves generic Doxil to combat drug shortageIt can pay to play with the FDA when it needs help with drug shortages. In a push to ease a months-long shortage of Johnson & Johnson's($JNJ)cancer drugDoxil, the FDA fast-tracked a generic fromSu2013/2/5